menu
    • menu

    Company profile for FibroGen

    NEW Drugs in Dev: 6
    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    Arlanda is your partner for the Brazil market.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We work at the intersection of groundbreaking science and patient need. Our research and development teams seek to identify and develop innovative drugs with the greatest promise of becoming first-in-class medicines for the treatment of chronic and life-threatening conditions such as anemia, idiopathic pulmonary fibrosis, pancreatic cancer, and Duchenne muscular dystrophy. Our product candidates leverage the body’s natural p...
    We work at the intersection of groundbreaking science and patient need. Our research and development teams seek to identify and develop innovative drugs with the greatest promise of becoming first-in-class medicines for the treatment of chronic and life-threatening conditions such as anemia, idiopathic pulmonary fibrosis, pancreatic cancer, and Duchenne muscular dystrophy. Our product candidates leverage the body’s natural pathways, providing us with the scientific insight to investigate their potential across multiple diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    FibroGenUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    409 Illinois Street San Francisco, CA 94158
    Telephone
    Telephone
    +1 415.978.1200
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.fibrogen.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/fibrogen
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    PBP World Meeting

    Not Confirmed

    envelop Contact Supplier

    PBP World Meeting

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Kyntra Bio To Report 2025 Full-Year Financial Results
    Kyntra Bio To Report 2025 Full-Year Financial Results

    09 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/09/3251671/33525/en/Kyntra-Bio-to-Report-Fourth-Quarter-and-Full-Year-2025-Financial-Results.html

    GLOBENEWSWIRE
    09 Mar 2026
    Share Share
    FibroGen Rebrands as Kyntra Bio, Signaling Fresh Momentum
    FibroGen Rebrands as Kyntra Bio, Signaling Fresh Momentum

    07 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/07/3214424/33525/en/FibroGen-Rebrands-as-Kyntra-Bio-to-Reflect-a-New-Era-of-Focus-and-Momentum.html

    GLOBENEWSWIRE
    07 Jan 2026
    Share Share
    Roxadustat Gains FDA Orphan Status for Myelodysplastic Syndromes
    Roxadustat Gains FDA Orphan Status for Myelodysplastic Syndromes

    15 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/15/3205285/33525/en/Roxadustat-Granted-Orphan-Drug-Designation-for-the-Treatment-of-Myelodysplastic-Syndromes-by-the-U-S-Food-and-Drug-Administration.html

    GLOBENEWSWIRE
    15 Dec 2025
    Share Share
    Fibrogen To Present At Oppenheimer Rare Disease Summit
    Fibrogen To Present At Oppenheimer Rare Disease Summit

    02 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/02/3198425/33525/en/FibroGen-to-Present-at-the-Oppenheimer-Movers-in-Rare-Disease-Summit.html

    GLOBENEWSWIRE
    02 Dec 2025
    Share Share
    Fibrogen Updates Q3 2025 Financials And Business Progress
    Fibrogen Updates Q3 2025 Financials And Business Progress

    10 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/10/3185020/33525/en/FibroGen-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    10 Nov 2025
    Share Share
    FibroGen to Report Third Quarter 2025 Financial Results
    FibroGen to Report Third Quarter 2025 Financial Results

    03 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/03/3179766/33525/en/FibroGen-to-Report-Third-Quarter-2025-Financial-Results.html

    GLOBENEWSWIRE
    03 Nov 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search